大禹生物
(871970)
| 流通市值：6.17亿 | | | 总市值：9.96亿 |
| 流通股本：6904.09万 | | | 总股本：1.11亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 29,472,938.03 | 122,511,959.17 | 89,245,304.8 | 57,253,634.38 |
| 营业收入 | 29,472,938.03 | 122,511,959.17 | 89,245,304.8 | 57,253,634.38 |
| 二、营业总成本 | 34,015,701.96 | 145,314,666.7 | 108,779,005.81 | 70,116,632.08 |
| 营业成本 | 23,576,272.31 | 91,912,539.65 | 67,439,901.2 | 43,634,214.94 |
| 税金及附加 | 142,082.26 | 2,397,329.45 | 1,209,822.09 | 1,060,388.35 |
| 销售费用 | 3,083,119.44 | 15,119,167.55 | 11,352,942.59 | 6,852,585.24 |
| 管理费用 | 4,843,486.54 | 24,924,712 | 20,376,309.51 | 12,910,864.22 |
| 研发费用 | 1,818,246.15 | 8,588,792.17 | 6,643,893.8 | 4,480,393.69 |
| 财务费用 | 552,495.26 | 2,372,125.88 | 1,756,136.62 | 1,178,185.64 |
| 其中:利息费用 | 524,228.08 | 2,391,334.78 | 1,773,421.15 | 1,190,522.25 |
| 其中:利息收入 | 9,454.26 | 41,525.87 | 34,300.87 | 23,733.98 |
| 加:公允价值变动收益 | -2,360 | - | - | - |
| 加:投资收益 | -238.16 | - | - | - |
| 资产减值损失(新) | - | -3,608,656.5 | -128,898.4 | -72,940.68 |
| 信用减值损失(新) | -4,058.25 | -3,398,262.74 | -730,386.79 | -341,040.08 |
| 其他收益 | 1,311,514.33 | 6,528,999.18 | 4,305,456.31 | 2,779,277.7 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -3,237,906.01 | -23,280,627.59 | -16,087,529.89 | -10,497,700.76 |
| 加:营业外收入 | 0.22 | 46,920.63 | 47,410.53 | 47,410.45 |
| 减:营业外支出 | 412.07 | 64,326.26 | 77,183.57 | - |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -3,238,317.86 | -23,298,033.22 | -16,117,302.93 | -10,450,290.31 |
| 减:所得税费用 | 1,252.5 | 644,661.46 | - | - |
| 六、净利润 | -3,239,570.36 | -23,942,694.68 | -16,117,302.93 | -10,450,290.31 |
| 持续经营净利润 | -3,239,570.36 | -23,942,694.68 | -16,117,302.93 | -10,450,290.31 |
| 归属于母公司股东的净利润 | -3,239,570.36 | -23,942,694.68 | -16,117,302.93 | -10,450,290.31 |
| (一)基本每股收益 | -0.03 | -0.22 | -0.14 | -0.09 |
| (二)稀释每股收益 | -0.03 | -0.22 | -0.14 | -0.09 |
| 九、综合收益总额 | -3,239,570.36 | -23,942,694.68 | -16,117,302.93 | -10,450,290.31 |
| 归属于母公司股东的综合收益总额 | -3,239,570.36 | -23,942,694.68 | -16,117,302.93 | -10,450,290.31 |
| 公告日期 | 2025-04-28 | 2025-04-28 | 2024-10-28 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |